{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:44:40Z","timestamp":1791200680943,"version":"4.2.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"South African National Research Foundation","award":["69035"],"award-info":[{"award-number":["69035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0258-4","type":"journal-article","created":{"date-parts":[[2015,7,27]],"date-time":"2015-07-27T10:18:32Z","timestamp":1437992312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Partial inhibition of the ubiquitin\u2013proteasome system ameliorates cardiac dysfunction following ischemia\u2013reperfusion in the presence of high glucose"],"prefix":"10.1186","volume":"14","author":[{"given":"Buin","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudo F","family":"Mapanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Faadiel","family":"Essop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"258_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","volume":"29","author":"S Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu S, Fuller J, Mulnier HE, Raleigh VS, Lawrenson R, Colhoun HM (2006) High risk of cardiovascular disease in a cohort study using the General Practice Research Database. Diabetes Care 29:798\u2013804","journal-title":"Diabetes Care"},{"issue":"12","key":"258_CR2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4103\/0972-5229.146315","volume":"18","author":"A Gardner","year":"2014","unstructured":"Gardner A (2014) The benefits of tight glycemic control in critical illness: sweeter than assumed? Indian J Crit Care Med 18(12):807","journal-title":"Indian J Crit Care Med"},{"issue":"4","key":"258_CR3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","volume":"5","author":"I Mart\u00edn-Tim\u00f3n","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, Sevillano-Collantes C, Segura-Galindo A, Ca\u00f1izo-G\u00f3mez FJ (2014) Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes 5(4):444\u2013470","journal-title":"World J Diabetes"},{"key":"258_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/dia.2010.0146","volume":"13","author":"ML Marcovecchio","year":"2011","unstructured":"Marcovecchio ML, Lucantoni M, Chiarelli F (2011) Role of chronic and cute hyperglycemia in the development of diabetes complications. Diabetes Technol Ther 13:389\u2013394","journal-title":"Diabetes Technol Ther"},{"key":"258_CR5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"United Kingdom Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"United Kingdom Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with T2DM (UKPDS 33). Lancet 352:837\u2013845","journal-title":"Lancet"},{"key":"258_CR6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977\u2013986","journal-title":"N Engl J Med"},{"key":"258_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29\u201334","journal-title":"Am J Cardiol"},{"key":"258_CR8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(99)08415-9","volume":"355","author":"SE Capes","year":"2000","unstructured":"Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773\u2013778","journal-title":"Lancet"},{"issue":"16","key":"258_CR9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2009.01.041","volume":"53","author":"R Marfella","year":"2009","unstructured":"Marfella R, Di Filippo C, Portoghese M, Ferraraccio F, Rizzo MR, Siniscalchi M et al (2009) Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 53(16):1425\u20131436","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"258_CR10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1532-5415.2008.01729.x","volume":"56","author":"I Sleiman","year":"2008","unstructured":"Sleiman I, Morandi A, Sabatini T, Ranhoff A, Ricci A, Rozzini R et al (2008) Hyperglycemia as a predictor of in-hospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit. J Am Geriatr Soc 56(6):1106\u20131110","journal-title":"J Am Geriatr Soc"},{"key":"258_CR11","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","volume":"359","author":"A Norhammar","year":"2002","unstructured":"Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efend\u00edc S, Ryd\u00e9n L et al (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140\u20132144","journal-title":"Lancet"},{"issue":"9","key":"258_CR12","first-page":"1121","volume":"81","author":"G Sawin","year":"2010","unstructured":"Sawin G, Shaughnessy AF (2010) Glucose control in hospitalized patients. Am Fam Physician 81(9):1121\u20131124","journal-title":"Am Fam Physician"},{"key":"258_CR13","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00062.2006","volume":"291","author":"SR Powell","year":"2006","unstructured":"Powell SR (2006) The ubiquitin\u2013proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 291:H1\u2013H19","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"258_CR14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1742-4658.2011.08456.x","volume":"279","author":"F Kriegenburg","year":"2012","unstructured":"Kriegenburg F, Ellgaard L, Hartmann-Petersen R (2012) Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J 279(4):532\u2013542","journal-title":"FEBS J"},{"issue":"4","key":"258_CR15","doi-asserted-by":"crossref","first-page":"H567","DOI":"10.1152\/ajpheart.00650.2012","volume":"304","author":"Y Wang","year":"2013","unstructured":"Wang Y, Sun W, Du B, Miao X, Bai Y, Xin Y et al (2013) Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-\u03baB. Am J Physiol Heart Circ Physiol 304(4):H567\u2013H578","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"258_CR16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.carpath.2008.09.008","volume":"18","author":"R Marfella","year":"2009","unstructured":"Marfella R, Di C, Portoghese M, Siniscalchi M, Martis S, Ferraraccio F et al (2009) The ubiquitin\u2013proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium : the role of glycemic control. Cardiovasc Pathol 18(6):332\u2013345","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"258_CR17","doi-asserted-by":"crossref","first-page":"H1298","DOI":"10.1152\/ajpheart.00765.2007","volume":"294","author":"S Huang","year":"2008","unstructured":"Huang S, Patterson E, Yu X, Garrett MW, De Aos I, Kem DC (2008) Proteasome inhibition 1\u00a0h following ischemia protects GRK2 and prevents malignant ventricular tachyarrhythmias and SCD in a model of myocardial infarction. Am J Physiol Heart Circ Physiol 294(3):H1298\u2013H1303","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"32","key":"258_CR18","doi-asserted-by":"crossref","first-page":"30057","DOI":"10.1074\/jbc.M100142200","volume":"276","author":"AL Bulteau","year":"2001","unstructured":"Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B et al (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion\/reperfusion. J Biol Chem 276(32):30057\u201330063","journal-title":"J Biol Chem"},{"issue":"3","key":"258_CR19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cardiores.2005.12.021","volume":"70","author":"O Zolk","year":"2006","unstructured":"Zolk O, Schenke C, Sarikas A (2006) The ubiquitin\u2013proteasome system: focus on the heart. Cardiovasc Res 70(3):410\u2013421","journal-title":"Cardiovasc Res"},{"issue":"3","key":"258_CR20","doi-asserted-by":"crossref","first-page":"H337","DOI":"10.1152\/ajpheart.00604.2012","volume":"304","author":"J Calise","year":"2013","unstructured":"Calise J, Powell SR (2013) The ubiquitin proteasome system and myocardial ischemia. Am J Physiol Heart Circ Physiol 304(3):H337\u2013H349","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"258_CR21","doi-asserted-by":"crossref","first-page":"e47322","DOI":"10.1371\/journal.pone.0047322","volume":"7","author":"R Mapanga","year":"2012","unstructured":"Mapanga R, Rajamani U, Dlamini N, Zungu-Edmondson M, Kelly-Laubscher R, Shafiullah M et al (2012) Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. PLoS One 7(10):e47322","journal-title":"PLoS One"},{"key":"258_CR22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/apha.12184","volume":"210","author":"RF Mapanga","year":"2014","unstructured":"Mapanga RF, Joseph D, Symington B, Garson K-L, Kimar C, Kelly-Laubscher R et al (2014) Detrimental effects of acute hyperglycaemia on the rat heart. Acta Physiol (Oxf) 210:546\u2013564","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"258_CR23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/med.20251","volume":"32","author":"F Harris","year":"2012","unstructured":"Harris F, Pierpoint L (2012) Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial agent. Med Res Rev 32(6):1292\u20131327","journal-title":"Med Res Rev"},{"key":"258_CR24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","volume":"268","author":"G Fenteany","year":"1995","unstructured":"Fenteany G, Standaert R, Lane W, Choi S, Corey E, Schreiber S (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726\u2013731","journal-title":"Science"},{"issue":"3","key":"258_CR25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/cr0502504","volume":"107","author":"L Borissenko","year":"2007","unstructured":"Borissenko L, Groll M (2007) 20S proteasome and its inhibitors: crystallographic knowledge for drug development. Chem Rev 107(3):687\u2013717","journal-title":"Chem Rev"},{"issue":"20","key":"258_CR26","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1074\/jbc.272.20.13437","volume":"272","author":"A Craiu","year":"1997","unstructured":"Craiu A, Gaczynska M, Akopian T, Gramm CF, Fenteany G, Goldberg AL et al (1997) Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem 272(20):13437\u201313445","journal-title":"J Biol Chem"},{"key":"258_CR27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.freeradbiomed.2005.09.022","volume":"40","author":"A Divald","year":"2006","unstructured":"Divald A, Powell SR (2006) Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic Biol Med 40:156\u2013164","journal-title":"Free Radic Biol Med"},{"key":"258_CR28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/ars.2005.7.538","volume":"7","author":"S Powell","year":"2005","unstructured":"Powell S, Wang P, Katzeff H, Shringarpure R, Teoh C, Khaliulin I et al (2005) Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal 7:538\u2013546","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"258_CR29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1748-1716.2011.02275.x","volume":"202","author":"U Rajamani","year":"2011","unstructured":"Rajamani U, Joseph D, Roux S, Essop MF (2011) The hexosamine biosynthetic pathway can mediate myocardial apoptosis in a rat model of diet-induced insulin resistance. Acta Physiol (Oxf) 202(2):151\u2013157","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"258_CR30","doi-asserted-by":"crossref","first-page":"C139","DOI":"10.1152\/ajpcell.00020.2010","volume":"299","author":"U Rajamani","year":"2010","unstructured":"Rajamani U, Essop MF (2010) Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299(1):C139\u2013C147","journal-title":"Am J Physiol Cell Physiol"},{"key":"258_CR31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/cvr\/cvp309","volume":"85","author":"X Yu","year":"2010","unstructured":"Yu X, Kem DC (2010) Proteasome inhibition during myocardial infarction. Cardiovasc Res 85:312\u2013320","journal-title":"Cardiovasc Res"},{"key":"258_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1006\/jmcc.1998.0880","volume":"31","author":"B Campbell","year":"1999","unstructured":"Campbell B, Adams J, Shin Y, Lefer A (1999) Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol 31:467\u2013476","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"258_CR33","doi-asserted-by":"crossref","first-page":"H919","DOI":"10.1152\/ajpheart.00851.2002","volume":"284","author":"J Pye","year":"2003","unstructured":"Pye J, Ardeshirpour F, McCain A, Bellinger DA, Merricks E, Adams J et al (2003) Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 284(3):H919\u2013H926","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"258_CR34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.athoracsur.2007.02.049","volume":"84","author":"WE Stansfield","year":"2007","unstructured":"Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH (2007) Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia\u2013reperfusion injury. Ann Thorac Surg 84(1):120\u2013125","journal-title":"Ann Thorac Surg"},{"key":"258_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","volume":"71","author":"X Wang","year":"2014","unstructured":"Wang X, Robbins J (2014) Proteasomal and lysosomal protein degradation and heart disease. J Mol Cell Cardiol 71:16\u201324","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"258_CR36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCRESAHA.112.270983","volume":"111","author":"Z Tian","year":"2012","unstructured":"Tian Z, Zheng H, Li J, Li Y, Su H, Wang X (2012) Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia\u2013reperfusion injury in Mice. Circ Res 111(5):532\u2013542","journal-title":"Circ Res"},{"issue":"8","key":"258_CR37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","volume":"8","author":"AF Kisselev","year":"2001","unstructured":"Kisselev AF, Goldberg AL (2001) Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8(8):739\u2013758","journal-title":"Chem Biol"},{"issue":"10","key":"258_CR38","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bcp.2011.03.009","volume":"81","author":"Y Ma","year":"2011","unstructured":"Ma Y, Chen B, Liu D, Yang Y, Xiong Z, Zeng J et al (2011) MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-\u03ba\u03b2\/TGF\u03b21 pathway. Biochem Pharmacol 81(10):1228\u20131236","journal-title":"Biochem Pharmacol"},{"key":"258_CR39","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1006\/bbrc.2002.6476","volume":"291","author":"K Stangl","year":"2002","unstructured":"Stangl K, G\u00fcnther C, Frank T, Lorenz M, Meiners S, R\u00f6pke T et al (2002) Inhibition of the ubiquitin\u2013proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun 291:542\u2013549","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"258_CR40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pcad.2007.11.005","volume":"51","author":"C Kassiotis","year":"2008","unstructured":"Kassiotis C, Rajabi M, Taegtmeyer H (2008) Metabolic reserve of the heart: the forgotten link between contraction and coronary flow. Prog Cardiovasc Dis 51(1):74\u201388","journal-title":"Prog Cardiovasc Dis"},{"issue":"14","key":"258_CR41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.98.14.1355","volume":"98","author":"LM Buja","year":"1998","unstructured":"Buja LM, Entman ML (1998) Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98(14):1355\u20131357","journal-title":"Circulation"},{"issue":"46","key":"258_CR42","doi-asserted-by":"crossref","first-page":"47985","DOI":"10.1074\/jbc.M405071200","volume":"279","author":"CL Murriel","year":"2004","unstructured":"Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D (2004) Protein kinase C delta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 279(46):47985\u201347991","journal-title":"J Biol Chem"},{"key":"258_CR43","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615\u20131625","journal-title":"Diabetes"},{"key":"258_CR44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s001250050729","volume":"40","author":"J Nourooz-Zadeh","year":"1997","unstructured":"Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B et al (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40:647\u2013653","journal-title":"Diabetologia"},{"key":"258_CR45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1006876607566","volume":"188","author":"P R\u00f6sen","year":"1998","unstructured":"R\u00f6sen P, Du X, Tsch\u00f6pe D (1998) Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention with alpha tocopherol? Mol Cell Biochem 188:103\u2013111","journal-title":"Mol Cell Biochem"},{"key":"258_CR46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.advenzreg.2003.11.013","volume":"44","author":"WD Holtzclaw","year":"2004","unstructured":"Holtzclaw WD, Dinkova-Kostova AT, Talalay P (2004) Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul 44:335\u2013367","journal-title":"Adv Enzyme Regul"},{"issue":"378","key":"258_CR47","first-page":"273","volume":"2004","author":"A Kobayashi","year":"2000","unstructured":"Kobayashi A, Ohta T, Yamamoto M (2000) Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol 2004(378):273\u2013286","journal-title":"Methods Enzymol"},{"issue":"24","key":"258_CR48","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","volume":"278","author":"M McMahon","year":"2003","unstructured":"McMahon M, Itoh K, Yamamoto M, Hayes JD (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278(24):21592\u201321600","journal-title":"J Biol Chem"},{"issue":"16","key":"258_CR49","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","volume":"24","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi A, Kang M, Okawa H, Zenke Y, Chiba T, Igarashi K et al (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24(16):7130\u20137139","journal-title":"Mol Cell Biol"},{"issue":"34","key":"258_CR50","doi-asserted-by":"crossref","first-page":"30091","DOI":"10.1074\/jbc.M501279200","volume":"280","author":"DD Zhang","year":"2005","unstructured":"Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M (2005) Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem 280(34):30091\u201330099","journal-title":"J Biol Chem"},{"issue":"3","key":"258_CR51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCRESAHA.109.208801","volume":"106","author":"MS Willis","year":"2010","unstructured":"Willis MS, Townley-Tilson WHD, Kang EY, Homeister JW, Patterson C (2010) Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res 106(3):463\u2013478","journal-title":"Circ Res"},{"issue":"7","key":"258_CR52","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","volume":"584","author":"VI Korolchuk","year":"2010","unstructured":"Korolchuk VI, Menzies FM, Rubinsztein DC (2010) Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 584(7):1393\u20131398","journal-title":"FEBS Lett"},{"issue":"3","key":"258_CR53","first-page":"214","volume":"1","author":"Q Zheng","year":"2011","unstructured":"Zheng Q, Su H, Tian Z, Wang X (2011) Proteasome malfunction activates macroautophagy in the heart. Am J Cardiovasc Dis 1(3):214\u2013226","journal-title":"Am J Cardiovasc Dis"},{"issue":"8","key":"258_CR54","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/jcmm.12312","volume":"18","author":"B Wang","year":"2014","unstructured":"Wang B, Yang Q, Sun YY, Xing YF, Bin WY, Lu XT et al (2014) Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J Cell Mol Med 18(8):1599\u20131611","journal-title":"J Cell Mol Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0258-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:28:15Z","timestamp":1498220895000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/14\/1\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0258-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]},"article-number":"94"}}